Abstract
We reported concurrent chemoradiation for postoperative recurrent esophageal cancer patients with lymph node metastases and a pulmonary metastasis. From October 2001 to January 2004, we treated 6 consecutive patients with radiation and concurrent chemotherapy using daily low-doses of CDDP and UFT-E. Of the 6 patients, 4 (67%) had a complete response and 2 (33%) a partial response, yielding an overall response rate of 100% (6/6). Five patients are now alive without cancers, and 1 patient died with cancer. Concurrent chemoradiation using daily low-doses of CDDP and UFT-E is feasible and seems to offer good results for recurrent esophageal cancer patients.
MeSH terms
-
Administration, Oral
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Squamous Cell / drug therapy*
-
Carcinoma, Squamous Cell / radiotherapy*
-
Carcinoma, Squamous Cell / secondary
-
Carcinoma, Squamous Cell / surgery
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Drug Administration Schedule
-
Esophageal Neoplasms / drug therapy*
-
Esophageal Neoplasms / pathology
-
Esophageal Neoplasms / radiotherapy*
-
Esophageal Neoplasms / surgery
-
Female
-
Humans
-
Lung Neoplasms / secondary
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Postoperative Period
-
Quality of Life
-
Radiotherapy Dosage
-
Tegafur / administration & dosage
-
Uracil / administration & dosage